<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00858897</url>
  </required_header>
  <id_info>
    <org_study_id>JDRF 1-2006-627-A</org_study_id>
    <nct_id>NCT00858897</nct_id>
  </id_info>
  <brief_title>Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A</brief_title>
  <official_title>Regulation of Glutathione Homeostasis in Adolescents With Type 1 Diabetes - Study A</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nemours Children's Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Juvenile Diabetes Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nemours Children's Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glutathione is normally present at high (millimolar) levels in blood and plays an important&#xD;
      role in the body's defense against oxidative stress, that is, against the damage caused to&#xD;
      the body by reactive oxygen species produced by the metabolism of most nutrients, including&#xD;
      glucose. Glutathione is a small peptide made from 3 amino acids, glutamate, cysteine, and&#xD;
      glycine.&#xD;
&#xD;
      This study is looking at how blood sugar levels may affect the way glutathione is made and&#xD;
      used by the body. Since glutathione is continuously synthesized and broken down, the amount&#xD;
      of glutathione present in blood depends on the balance between its rate of synthesis and its&#xD;
      rate of use.&#xD;
&#xD;
      In earlier studies, the investigators found that in poorly controlled diabetic teenagers,&#xD;
      glutathione was low, not because its production was decreased, but because it was used at an&#xD;
      excessive rate. In this study, the investigators want to determine how short-term changes in&#xD;
      blood sugar levels affect glutathione levels. This will help improve our understanding of how&#xD;
      diabetes affects metabolism.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adolescents with uncomplicated T1D will receive two, 5-hour infusions of deuterium-labeled&#xD;
      cysteine on 2 separate days, a few weeks apart, while blood glucose will be maintained, using&#xD;
      intravenous insulin infusion:&#xD;
&#xD;
        -  in the hyper-glycemic range (200-250 mg/dL) on one study day, and&#xD;
&#xD;
        -  near normoglycemia (80-140 mg/dL) on the other study day.&#xD;
&#xD;
      The order of the study days will be randomized.&#xD;
&#xD;
      We will determine whether the level of blood glucose at the time of study affects blood&#xD;
      glutathione concentration, and, if so, whether this is associated with changes in the&#xD;
      fractional rate of glutathione synthesis, as determined from the incorporation of labeled&#xD;
      cysteine into blood glutathione over the course of the 5-hr infusion of labeled cysteine.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase in glutathione concentration under normoglycemia</measure>
    <time_frame>Hyperglycemic study day vs. Normoglycemic study day, 1-2 weeks apart</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normoglycemia (80-140 mg/dL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyperglycemia (200-250 mg/dL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cysteine isotope infusion at normoglycemia vs hyperglycemia</intervention_name>
    <description>L-[3,3-2H2]cysteine</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Regular Insulin</intervention_name>
    <description>Regular insulin, IV, as needed to maintain blood glucose in near-normoglycemic range (80-140 mg/dL) or hyperglycemic range (200-250 mg/mL) during metabolic studies</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 1 diabetes, using usual criteria such as: glycosuria, hyperglycemia prior to&#xD;
             treatment&#xD;
&#xD;
          -  BMI &lt;25 kg/m2&#xD;
&#xD;
          -  Age 14-18&#xD;
&#xD;
          -  HbA1c&gt;7.5%&#xD;
&#xD;
          -  No evidence of diabetic complications&#xD;
&#xD;
          -  Written informed consent from parents or legal guardian, and assent from patient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of significant anemia (hemoglobin &lt;11g/dL)&#xD;
&#xD;
          -  Presence of intercurrent illness such as infection&#xD;
&#xD;
          -  Presence of chronic disease such as other endocrine deficiency, chronic respiratory or&#xD;
             cardiac disease&#xD;
&#xD;
          -  Chronic use of medication other than insulin&#xD;
&#xD;
          -  Use of vitamin or mineral supplements within 2 weeks of study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Darmaun, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nemours Children's Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nemours Children's Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>March 6, 2009</study_first_submitted>
  <study_first_submitted_qc>March 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2009</study_first_posted>
  <last_update_submitted>July 14, 2009</last_update_submitted>
  <last_update_submitted_qc>July 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dominique Darmaun, MD, PhD</name_title>
    <organization>Nemours Children's Clinic</organization>
  </responsible_party>
  <keyword>Glutathione</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin, Globin Zinc</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

